Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic glucose for post-operative air leaks (PLUG-I)
NCT03905408Phase 1Completed
- Start
- Sep 2019
- Primary completion
- Feb 2021
- Countries
- 1
01
Overview
Phase 1, open-label trial of dextrose in air leak syndrome (ALS) (4 arms). Primary endpoint: Treatment-related adverse events at 1 year. Started Sep 2019; status: completed.
02
Drugs
dextrose
03
Conditions
air leak syndrome (ALS)
Beyond the preview
Go deeper on NCT03905408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905408.